Recent studies by Mauro et al. also demonstrated that in breast cancer MDA-MB-231 xenograft models, the pre-treatment with adiponectin reduced tumor growth via amplifying AMP kinase signaling and reducing cyclin D1 expression [42,43]. This evidence concerns the gene ADIPOQ and neoplasm.